Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
China
202110829496.3
Filed on 2021-07-22
202110829496.3
Filed on 2021-07-22
TARGETING THE CHOLECYSTOKININ-B RECEPTOR FOR IMAGING AND EARLY DETECTION OF PANCREATIC CANCER AND PRE-CANCEROUS LESIONS
Patent Cooperation Treaty
PCT/US2021/034339
Filed on 2021-05-26
PCT/US2021/034339
Filed on 2021-05-26
HYBRID NUCLEIC ACID SWITCHES
US Application 17/602,204
Filed on 2021-10-07
Filed on 2021-10-07
Anti-Human Papillomavirus 16 E6 T Cell Receptors
Japan
2021-166407
Filed on 2021-10-08
2021-166407
Filed on 2021-10-08
Synthetic Lethality-Mediated Precision Oncology via the Tumor Transcriptome
Patent Cooperation Treaty
PCT/US2021/057229
Filed on 2021-10-29
PCT/US2021/057229
Filed on 2021-10-29
Chimeric Antigen Receptors Targeting B-cell Maturation Antigen
US Patent 12,180,484
Filed on 2022-05-16
Filed on 2022-05-16
STAT3 INHIBITOR FORMULATION
Sweden
18720845.9
Filed on 2018-04-05
18720845.9
Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION
Poland
18720845.9
Filed on 2018-04-05
18720845.9
Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION
The Netherlands
18720845.9
Filed on 2018-04-05
18720845.9
Filed on 2018-04-05
STAT3 INHIBITOR FORMULATION
Italy
18720845.9
Filed on 2018-04-05
18720845.9
Filed on 2018-04-05